AD
Healthcare & Life Sciences
Adimab
United Stateswww.adimab.com/
Adimab is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About Adimab
Adimab is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Adimab provides a proprietary yeast-based antibody discovery and engineering platform that enables biopharma partners to develop therapeutic antibodies and proteins for clinical use.
Explore Adimab's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.